The broken lines in the drawings show portions of the inhaler that form no part of the claimed design.
The broken lines in the drawings show portions of the inhaler that form no part of the claimed design.
Number | Date | Country | Kind |
---|---|---|---|
007255740 | Nov 2019 | EM | regional |
Number | Name | Date | Kind |
---|---|---|---|
D307388 | Newell | Apr 1990 | S |
D459252 | Radivojevic | Jun 2002 | S |
D460255 | Hillman | Jul 2002 | S |
D472372 | Hassett | Apr 2003 | S |
D502807 | Jaron | Mar 2005 | S |
D590283 | Critelli | Apr 2009 | S |
D593884 | Wang | Jun 2009 | S |
D609009 | Schaal | Feb 2010 | S |
D637281 | Harvey | May 2011 | S |
D667105 | Zuyderhoudt | Sep 2012 | S |
D684684 | Grunstad | Jun 2013 | S |
D693458 | Wright | Nov 2013 | S |
D720096 | McDougall | Dec 2014 | S |
D726966 | McDougall | Apr 2015 | S |
D755950 | Meliniotis | May 2016 | S |
D782350 | Bridges | Mar 2017 | S |
D783429 | Wortelboer | Apr 2017 | S |
D791931 | Kang | Jul 2017 | S |
D831190 | Von Schuckmann | Oct 2018 | S |
D855792 | Toksoz | Aug 2019 | S |
D869638 | Shinichi | Dec 2019 | S |
D885850 | Trani | Jun 2020 | S |
20080196718 | Connell | Aug 2008 | A1 |
20100126507 | Lulla | May 2010 | A1 |
20120097162 | Keegstra | Apr 2012 | A1 |
20120132205 | Meliniotis | May 2012 | A1 |
20120138055 | Meliniotis | Jun 2012 | A1 |
20150096563 | Toksoz | Apr 2015 | A1 |
20150151059 | Meliniotis | Jun 2015 | A1 |
20150174345 | Toksoz | Jun 2015 | A1 |
20160045684 | Ono | Feb 2016 | A1 |
20160175547 | Nakamura | Jun 2016 | A1 |
20180214647 | Meliniotis | Aug 2018 | A1 |
20190255264 | Toksoz | Aug 2019 | A1 |
20210268214 | Clarke | Sep 2021 | A1 |
Number | Date | Country |
---|---|---|
306218929 | Dec 2020 | CN |
007343769-0001 | Dec 2019 | EM |
D1590925 | Nov 2017 | JP |
D1670251 | Oct 2020 | JP |
Entry |
---|
[Vectura Signs Global Agreement With Hikma to Develop Generic Versions of GSK's Ellipta® Portfolio], vectura.com, announced Year 2018 [online], [site visited Sep. 10, 2021], Internet URL: https://www.vectura.com/wp-content/uploads/2020/03/Vectura_Briefing_Document_19.12.18_v8.1.pdf (Year: 2018). |
[Vectura Expands Dry Powder Inhaler Development and Manufacturing Capabilities at its Facility in Chippenham, U.K.], vectura.com, announced Year 2021 [online], [site visited Sep. 10, 2021], Internet URL: https://www.vectura.com/about/news/vectura-expands-dry-powder-inhaler-development-and-manufacturing-capabilities-at-its-facility-in-chippenham-u-k/ (Year: 2021). |